Prospera Financial Services Inc Annexon, Inc. Transaction History

Prospera Financial Services Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 08, 2023	SELL	$2.1 - $6.37 $3,355 - $10,179	-1,598 Reduced 12.61%	11,078 $38,000
Q1 2023 May 12, 2023	BUY	$3.74 - $7.46 $47,408 - $94,562	12,676 New	12,676 $48,000
Q2 2022 Aug 08, 2022	SELL	$2.11 - $4.06 $17,531 - $33,734	-8,309 Closed	0 $0
Q1 2022 May 04, 2022	BUY	$2.73 - $11.94 $22,683 - $99,209	8,309 New	8,309 $23,000

146

102M

178K

159K

Ticker ANNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,617,700
Market Cap $245M
Description
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...

Get notified when there are updates to the investment portfolio of Prospera Financial Services Inc, based on Form 13F filings with the SEC.

Stay updated on Prospera Financial Services Inc with notifications on news.